The involvement of epigenetic control of this dietary combinatorial treatment in regulating ERα expression and subsequent enhanced efficacy of TAM chemotherapy provides new avenues for prevention and therapeutic application for de novo hormone-resistant breast cancer patients. The gene discussed is ESR1; the disease is breast cancer.